Cormorant Asset Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-900,000
| Closed | -$13.1M | – | 78 |
|
|
2021
Q4 | $13.1M | Sell |
900,000
-600,000
| -40% | -$8.72M | 0.78% | 37 |
|
|
2021
Q3 | $27M | Sell |
1,500,000
-500,000
| -25% | -$9M | 1.1% | 30 |
|
|
2021
Q2 | $35.1M | Hold |
2,000,000
| – | – | 1.19% | 24 |
|
|
2021
Q1 | $50.4M | Buy |
+2,000,000
| New | +$50.4M | 1.12% | 19 |
|
|
2019
Q4 | – | Sell |
-250,000
| Closed | -$270K | – | 63 |
|
|
2019
Q3 | $270K | Hold |
250,000
| – | – | 0.02% | 66 |
|
|
2019
Q2 | $548K | Sell |
250,000
-170,555
| -41% | -$374K | 0.03% | 64 |
|
|
2019
Q1 | $2.52M | Sell |
420,555
-57,500
| -12% | -$344K | 0.17% | 59 |
|
|
2018
Q4 | $3.53M | Sell |
478,055
-21,945
| -4% | -$162K | 0.29% | 52 |
|
|
2018
Q3 | $7.26M | Sell |
500,000
-25,538
| -5% | -$371K | 0.47% | 40 |
|
|
2018
Q2 | $10.5M | Hold |
525,538
| – | – | 0.78% | 37 |
|
|
2018
Q1 | $9.21M | Sell |
525,538
-24,462
| -4% | -$429K | 0.69% | 27 |
|
|
2017
Q4 | $13.6M | Hold |
550,000
| – | – | 1.42% | 21 |
|
|
2017
Q3 | $14.2M | Sell |
550,000
-170,000
| -24% | -$4.39M | 2.51% | 13 |
|
|
2017
Q2 | $19.5M | Sell |
720,000
-80,000
| -10% | -$2.17M | 3.24% | 9 |
|
|
2017
Q1 | $23.9M | Sell |
800,000
-176,286
| -18% | -$5.26M | 3.46% | 8 |
|
|
2016
Q4 | $26.5M | Buy |
976,286
+75,000
| +8% | +$2.04M | 3.57% | 8 |
|
|
2016
Q3 | $23.1M | Hold |
901,286
| – | – | 2.55% | 12 |
|
|
2016
Q2 | $16.6M | Buy |
901,286
+253,342
| +39% | +$4.68M | 2.36% | 15 |
|
|
2016
Q1 | $12.3M | Hold |
647,944
| – | – | 1.85% | 19 |
|
|
2015
Q4 | $17.5M | Buy |
+647,944
| New | +$17.5M | 2.09% | 15 |
|